CARLOS JESUS
DUEÑAS GUTIERREZ
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Hospital del Mar
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital del Mar (11)
2021
-
Redefining therapeutic success in HIV patients: An expert view
Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 10, pp. 2501-2518
2020
-
Outcomes of COVID-19 Among Hospitalized Patients With Non-dialysis CKD
Frontiers in Medicine, Vol. 7
2019
-
Recommendations from a panel of experts on the usefulness of fidaxomicin for the treatment of infections caused by Clostridium difficile
Revista Espanola de Quimioterapia, Vol. 32, Núm. 1, pp. 50-59
-
Rhodomyrtone decreases Staphylococcus aureus SigB activity during exponentially growing phase and inhibits haemolytic activity within membrane vesicles
Microbial Pathogenesis, Vol. 128, pp. 112-118
2018
-
Erratum for del Barrio-Tofiño et al., "Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain"
Antimicrobial agents and chemotherapy
2017
-
Genomics and susceptibility profiles of extensively drug-resistant pseudomonas aeruginosa isolates from Spain
Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 11
-
High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2102-2109
2016
-
Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study
Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 732.e1-732.e8
2014
-
Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin
Journal of Antimicrobial Chemotherapy
-
Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals
Clinical Microbiology and Infection, Vol. 20, Núm. 4, pp. 361-367
2008
-
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903
Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092